Literature DB >> 27789777

Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit.

Yu-Yin Liu1, Wen-Liang Fang2, Frank Wang3, Jun-Te Hsu1, Chun-Yi Tsai1, Keng-Hao Liu1, Chun-Nan Yeh1, Tse-Ching Chen4, Ren-Chin Wu4, Cheng-Tang Chiu5, Ta-Sen Yeh6.   

Abstract

BACKGROUND: The present study assessed the impact of the retrieval of >25 lymph nodes (LNs) on the survival outcome of patients with advanced gastric cancer after curative-intent gastrectomy. PATIENTS AND METHODS: A total of 5,386 patients who had undergone curative gastrectomy for gastric cancer from 1994 to 2011 were enrolled. The clinicopathological parameters and overall survival (OS) were analyzed according to the number of LNs examined (≤15, n = 916; 16-25, n = 1,458; and >25, n = 3,012).
RESULTS: The percentage of patients with >25 LNs retrieved increased from 1994 to 2011. Patients in the LN >25 group were more likely to have undergone total gastrectomy and to have a larger tumor size, poorer tumor differentiation, and advanced T and N stages. Hospital mortality among the LN ≤15, LN 16-25, and LN >25 groups was 6.1%, 2.7%, and 1.7%, respectively (p < .0001). The LN >25 group consistently exhibited the most favorable OS, in particular, with stage II disease (p = .011) when OS was stratified according to tumor stage. Similarly, the LN >25 group had significantly better OS in all nodal stages (from N1 to N3b). The discrimination power of the lymph node ratio (LNR) for the LN ≤15, LN 16-25, and LN >25 groups was 483, 766, and 1,560, respectively. Multivariate analysis demonstrated that the LNR was the most important prognostic factor in the LN >25 group.
CONCLUSION: Retrieving more than 25 lymph nodes during curative-intent gastrectomy substantially improved survival and survival stratification of advanced gastric cancer without compromising patient safety. The Oncologist 2017;22:97-106Implications for Practice: D2 lymph node (LN) dissection is currently the standard of surgical management of gastric cancer, which is rarely audited by a third party. The present study, one of the largest surgical series worldwide, has shown that the traditionally recognized retrieval of ≥16 LNs during curative-intent gastrectomy might not be adequate in regions in which locally advanced gastric cancers predominate. The presented data show that retrieval of >25 LNs, which more greatly mimics D2 dissection, improves long-term outcomes and survival stratification without compromising patient safety. © AlphaMed Press 2016.

Entities:  

Keywords:  Gastrectomy; Gastric cancer; Long‐term survival; Lymph node retrieval

Mesh:

Year:  2016        PMID: 27789777      PMCID: PMC5313276          DOI: 10.1634/theoncologist.2016-0239

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  27 in total

1.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

2.  Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.

Authors:  Roderich E Schwarz; David D Smith
Journal:  Ann Surg Oncol       Date:  2006-11-09       Impact factor: 5.344

3.  Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience.

Authors:  Joyce Wong; Shams Rahman; Nadia Saeed; Hui-Yi Lin; Khaldoun Almhanna; Ravi Shridhar; Sarah Hoffe; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

4.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

5.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma.

Authors:  D M Dent; M V Madden; S K Price
Journal:  Br J Surg       Date:  1988-02       Impact factor: 6.939

6.  Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.

Authors:  Johan L Dikken; Edwin P M Jansen; Annemieke Cats; Berdine Bakker; Henk H Hartgrink; Elma Meershoek-Klein Kranenbarg; Henk Boot; Hein Putter; Koen C M J Peeters; Cornelis J H van de Velde; Marcel Verheij
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

7.  Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?

Authors:  A Biondi; D D'Ugo; F C M Cananzi; V Papa; A Borasi; F Sicoli; M Degiuli; G Doglietto; R Persiani
Journal:  Eur J Surg Oncol       Date:  2015-04-08       Impact factor: 4.424

8.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

9.  Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.

Authors:  X-J Wu; R-L Miao; Z-Y Li; Z-D Bu; L-H Zhang; A-W Wu; X-L Zong; S-X Li; F Shan; X Ji; H Ren; J-F Ji
Journal:  Eur J Surg Oncol       Date:  2015-04-03       Impact factor: 4.424

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  17 in total

1.  Survival impact of the number of lymph node retrieved on patients with node-negative gastric cancer: more is better?

Authors:  Jun-Te Hsu; Puo-Hsien Le; Chia-Jung Kuo; Ta-Sen Yeh; Yi-Yin Jan
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-07

2.  Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.

Authors:  Yinping Dong; Yiran Qiu; Jingyu Deng; Wei Wang; Zhe Sun; Zhenning Wang; Zhiwei Zhou; Huimian Xu; Han Liang
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-07       Impact factor: 4.553

3.  Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched.

Authors:  Chun-Yi Tsai; Tien-An Lin; Shih-Chiang Huang; Jun-Te Hsu; Chun-Nan Yeh; Tse-Ching Chen; Cheng-Tang Chiu; Jen-Shi Chen; Ta-Sen Yeh
Journal:  Oncologist       Date:  2020-02-14

4.  Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.

Authors:  Changhao Chen; Yuming Luo; Wang He; Yue Zhao; Yao Kong; Hongwei Liu; Guangzheng Zhong; Yuting Li; Jun Li; Jian Huang; Rufu Chen; Tianxin Lin
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

5.  Impact of Textbook Oncologic Outcome Attainment on Survival After Gastrectomy: A Review of the National Cancer Database.

Authors:  Megan A Cibulas; Azalia Avila; Ashwin M Mahendra; Shenae K Samuels; Christopher J Gannon; Omar H Llaguna
Journal:  Ann Surg Oncol       Date:  2022-08-16       Impact factor: 4.339

6.  Clinical value of peripheral blood microRNA detection in evaluation of SOX regimen as neoadjuvant chemotherapy for gastric cancer.

Authors:  Bibo Tan; Yong Li; Yan Di; Liqiao Fan; Qun Zhao; Qingwei Liu; Dong Wang; Nan Jia
Journal:  J Clin Lab Anal       Date:  2017-11-23       Impact factor: 2.352

7.  Retrieval of 30 Lymph Nodes Is Mandatory for Selected Stage II Gastric Cancer Patients.

Authors:  Yong-He Chen; Jun Lu; Run-Cong Nie; Dan Liu; Ai-Hong Liu; Zi-Jian Deng; Xi-Jie Chen; Jun Xiang; Ying-Bo Chen; Chang-Ming Huang; Shi Chen; Jun-Sheng Peng
Journal:  Front Oncol       Date:  2021-04-30       Impact factor: 6.244

8.  Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era-A Single Institute Experience over a Decade.

Authors:  Harsh Kanhere; Raghav Goel; Ben Finlay; Markus Trochsler; Guy Maddern
Journal:  Int J Surg Oncol       Date:  2018-01-14

Review 9.  Optimal management of resected gastric cancer.

Authors:  Riccardo Giampieri; Michela Del Prete; Luca Cantini; Maria Giuditta Baleani; Alessandro Bittoni; Elena Maccaroni; Rossana Berardi
Journal:  Cancer Manag Res       Date:  2018-06-21       Impact factor: 3.989

10.  Comparison of a Tumor-Ratio-Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer.

Authors:  Miaoquan Zhang; Chao Ding; Lin Xu; Biyi Ou; Shoucheng Feng; Guoqiang Wang; Wei Wang; Yao Liang; Yingbo Chen; Zhiwei Zhou; Haibo Qiu
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.